Supot, Ronie B.

HRN: 15-35-32  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2022
CEFTRIAXONE 1G (VIAL)
11/22/2022
11/28/2022
IV
2g
OD
Cellulitis
Waiting Final Action 
11/22/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/22/2022
11/28/2022
IV
600mg
Q8
Cellulitis
Waiting Final Action 
11/25/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/25/2022
12/02/2022
IV
2.25gms
Q12
Cellulitis W/ Elevated Crea
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: